
Clinical Pathways
Latest Content
Latest Videos

Shorts

Podcasts
More News

With radiopharmaceutical therapy use up 20 times in Medicare, experts analyze clinical pathways for delivering it in academic and community settings.


From an interview conducted during Patient-Centered Oncology Care 2023.







Each disease group guides and approves OneOncology clinical pathways to reflect evidenced-based national guidelines, which are updated often as new trial results are published or presented at major scientific meetings.



Applicants should show how they would measure biosimilars use and safety in both academic and community practice settings.

The savings occurred even while more patients in the health system were enrolling in clinical trials, according to an abstract presented during the American Society of Clinical Oncology 2020 Virtual meeting.

Administrator Seema Verma said the proposal would create opportunities "for drug manufacturers to have skin in the game through payment arrangements that challenge them to put their money where their mouth is."

Researchers warned that financial incentives that focus on a percentage of pathway compliance could “paradoxically harm the quality of care."

Three abstracts presented at this year’s annual meeting of the American Society of Clinical Oncology focused on cardiotoxic effects of cancer treatment and how cardiac disease remains a barrier to effective cancer therapy among patients with cancer and survivors.


CMS Administrator Seema Verma announced the update today in a blog post in Health Affairs.

Debra A. Patt, MD, MPH, MBA, a breast cancer specialist at Texas Oncology is the lead author on the study being presented at ASCO.







